Young Ha Ahn Selected Research

Immunotherapy

1/2023	Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma.
9/2020	Pharmacological Activation of Estrogen Receptor Beta Overcomes Tumor Resistance to Immune Checkpoint Blockade Therapy.
1/2020	A three-dimensional hyaluronic acid-based niche enhances the therapeutic efficacy of human natural killer cell-based cancer immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Young Ha Ahn Research Topics

Disease

3	Neoplasms (Cancer) 01/2023 - 01/2020
2	Infections 01/2017 - 10/2016
1	Alzheimer Disease (Alzheimer's Disease) 07/2023
1	Neuroinflammatory Diseases 07/2023
1	Brain Injuries (Brain Injury) 07/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Hemorrhage 08/2016
1	Dyspnea (Shortness of Breath) 08/2016

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 07/2023 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2023 - 09/2020
2	Tryptophan-tRNA LigaseIBA 01/2017 - 10/2016
1	Purinergic P2X7 ReceptorsIBA 07/2023
1	ChemokinesIBA 07/2023
1	erteberelIBA 09/2020
1	Therapeutic UsesIBA 09/2020
1	Estrogen Receptor betaIBA 09/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	TicagrelorIBA 08/2016
1	Purinergic P2Y Receptor AntagonistsIBA 08/2016

Therapy/Procedure

3	Immunotherapy 01/2023 - 01/2020
2	Therapeutics 01/2023 - 09/2020